Dr. Lyndsay Jean Willmott, MD

Dr. Willmott practices at HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth.

Dr. Willmott's NPI, 1043229529, was assigned on August 5, 2006. Dr. Willmott graduated from State University of New York at Buffalo School of Medicine in 2003. Dr. Willmott holds Arizona license 46677.

Dr. Willmott's primary practice is HonorHealth John C. Lincoln Medical Center, at 250 East Dunlap Avenue, Phoenix, AZ 85020 in Maricopa County. The practice phone is (602) 943-2381.

Dr. Willmott's primary practice is HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth. Dr. Willmott is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is District Medical Group. Dmand AI also links Dr. Willmott to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Willmott practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Willmott's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Willmott is licensed in Arizona.

CMS data shows 338 Medicare services from Dr. Willmott across 7 procedure codes in 2024, for 180 Medicare patients. Medicare paid $42,299 for them.

CMS counts 180 Medicare patients who saw Dr. Willmott in 2024. The largest group is 65 to 74, with 96 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Willmott's median patient age at 61, with 99% women.

In 2024, Dr. Willmott wrote 300 Medicare Part D claims for 90 patients. 95% of them were for generic drugs. CMS names the drug for 208 of them, across 7 drugs with 11 or more claims each, at $3,445 in total drug cost. In 2023, CMS named 190 claims across 6 drugs.

Dr. Willmott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Willmott as offering telehealth. CMS counts 22 procedures of removal of the uterus by Dr. Willmott, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Willmott, published from 2016 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Ovarian Neoplasms. Dr. Willmott has published most often in Gynecol Oncol. Dr. Willmott's most frequent co-authors are Bradley J. Monk, MD, Bhavana Pothuri, MD and Carol Aghajanian, MD.

Dmand AI links Dr. Willmott to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Biliary Tract Neoplasms, Ovarian Neoplasms and Ovarian Diseases.

CMS Open Payments shows 652 general payments to Dr. Willmott from 61 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $133,962. It also lists 4 research payments totaling $1,599 from 2020 to 2021.

Dr. Willmott graduated from State University of New York at Buffalo School of Medicine in 2003.